C1-inhibitor efficiently delays clot development in normal human whole blood and inhibits Escherichia coli-induced coagulation measured by thromboelastometry-Reference-Cited by-同舟云学术

C1-inhibitor efficiently delays clot development in normal human whole blood and inhibits Escherichia coli-induced coagulation measured by thromboelastometry

Published:2016-07 Issue: Volume:143 Page:63-70
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Landsem A.,Fure H.,Mollnes T.E.,Nielsen E.W.,Brekke O.L.

Funder

Research Council of Norway

Norwegian Council on Cardiovascular Disease

Northern Norway Regional Health Authority

Southern and Eastern Norway Regional Health Authority

Odd Fellow Foundation

European Community's Seventh Framework Programme

Publisher

Elsevier BV

Subject

Hematology

Reference39 articles.

1. Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization;Bock;Biochemistry,1986

2. Biochemistry and pathophysiology of human C1 inhibitor: current issues;Schapira;Complement,1985

3. Concentration of C1 inhibitor in sera of healthy blood donors as studied by immunoenzymatic assay;Gregorek;Complement Inflamm.,1991

4. C1-inhibitor: more than a serine protease inhibitor;Zeerleder;Semin. Thromb. Hemost.,2011

5. Biological activities of C1 inhibitor;Davis;Mol. Immunol.,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment;Frontiers in Immunology;2022-04-01

2. Plasma-derived and recombinant C1 esterase inhibitor: Binding profiles and neuroprotective properties in brain ischemia/reperfusion injury;Brain, Behavior, and Immunity;2021-03

3. More than a Pore: Nonlytic Antimicrobial Functions of Complement and Bacterial Strategies for Evasion;Microbiology and Molecular Biology Reviews;2021-02-17

4. Identification of potential coagulation pathway abnormalities in SARS-Cov-2 infection; insights from bioinformatics analysis;2020-12-07

5. Thromboembolic Risk of C1 Esterase Inhibitors: A Systematic Review on Current Evidence;Expert Review of Clinical Pharmacology;2020-06-04